Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Beckendorf

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|November 27, 2025
Exploring the Safety of Sodium-Glucose Co-Transporter 2 Inhibitors in Left Ventricular Assist Device Patients: Clinical Outcomes in a Multicenter ExperienceSonja Hamed, Nikolaos Kalampokas, Jan Beckendorf, et al.
ESC Heart Failure|July 10, 2018
The need for dedicated advanced heart failure units to optimize heart failure care: impact of optimized advanced heart failure unit care on heart transplant outcome in high-risk patientsMichael M Kreusser, Ramon Tschierschke, Jan Beckendorf, et al.
EMBO Molecular Medicine|September 7, 2014
CaM Kinase II mediates maladaptive post-infarct remodeling and pro-inflammatory chemoattractant signaling but not acute myocardial ischemia/reperfusion injuryMartin Weinreuter, Michael M Kreusser, Jan Beckendorf, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|November 27, 2025
Exploring the Safety of Sodium-Glucose Co-Transporter 2 Inhibitors in Left Ventricular Assist Device Patients: Clinical Outcomes in a Multicenter ExperienceSonja Hamed, Nikolaos Kalampokas, Jan Beckendorf, et al.
ESC Heart Failure|July 10, 2018
The need for dedicated advanced heart failure units to optimize heart failure care: impact of optimized advanced heart failure unit care on heart transplant outcome in high-risk patientsMichael M Kreusser, Ramon Tschierschke, Jan Beckendorf, et al.
EMBO Molecular Medicine|September 7, 2014
CaM Kinase II mediates maladaptive post-infarct remodeling and pro-inflammatory chemoattractant signaling but not acute myocardial ischemia/reperfusion injuryMartin Weinreuter, Michael M Kreusser, Jan Beckendorf, et al.
Pageof 2